Search for: "In re: Abbott Laboratories"
Results 41 - 60
of 216
Sorted by Relevance
|
Sort by Date
26 Mar 2009, 12:32 am
" Abbott Laboratories v. [read post]
28 Apr 2022, 4:17 pm
On another occasion product was not re-called from the market even after management became aware of a nonconformity (“NC”). [read post]
7 Jan 2013, 3:30 am
They’re lucky to find one. [read post]
30 Aug 2017, 12:00 pm
Like many wireless devices, pacemakers from Abbott Laboratories contain critical flaws that allow hijackers within radio range to seize control while the pacemakers are running. [read post]
3 Dec 2009, 10:16 pm
Supporters can click the Make it Happen link and send an email to the CEOs of Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer Inc. and Sequoia Pharmaceuticals Inc. [read post]
11 Nov 2011, 11:55 am
Abbott Laboratories, 2011 U.S. [read post]
2 Jul 2015, 12:06 pm
”Abbott Labs. v. [read post]
6 Aug 2009, 6:50 am
Abbott Laboratories, ___ F. [read post]
14 Jan 2018, 6:34 am
Abbott Laboratories, 26 Cal.3d at p. 611.) [read post]
14 Aug 2014, 5:14 am
Deborah Malin worked in the IT department of the Abbott Laboratories’s hospital product division (spun off to a new company, Hospira, in 2006). [read post]
17 Jun 2010, 6:47 am
Abbott Laboratories, Inc. [read post]
2 Jun 2022, 12:56 pm
Here are the whistleblower documents – Redacted Confidential Disclosure re Abbott Laboratories – 10-19-2021_Redacted (1) Here is the 2022 inspection report at the plant – Updated Final Applied_Unapplied Redactions Abbott Nutrition Sturgis FEI 1815692 FDA 483 1-31022 to 3-16-22 – ISSUED_Redacted Here is the complaint – abbott_complaint_0 Here is the consent decree – abbott_proposed_consent_decree_0 Please read… [read post]
3 Jun 2022, 9:30 am
Here are the whistleblower documents – Redacted Confidential Disclosure re Abbott Laboratories – 10-19-2021_Redacted (1) Here is the 2022 inspection report at the plant – Updated Final Applied_Unapplied Redactions Abbott Nutrition Sturgis FEI 1815692 FDA 483 1-31022 to 3-16-22 – ISSUED_Redacted Here is the complaint – abbott_complaint_0 Here is the consent decree – abbott_proposed_consent_decree_0 Please read… [read post]
4 Jan 2013, 4:15 am
Abbott Laboratories paid $1.4 billion. [read post]
25 Oct 2008, 12:03 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Biaxin (Clarithromycin) - US: New standard for materiality: Abbott Laboratories v. [read post]
6 Jun 2011, 4:58 pm
At the time, Daughter was a corporate associate in the Los Angeles office of a large, international law firm (the “Firm”) who was working on an impending merger and acquisition involving Abbott Laboratories (“Abbott”) and her Firm’s client, Advanced Medical Optics, Inc. [read post]
16 Jun 2010, 3:02 pm
Kappos (Patent Docs) Niaspan (Niacin) – US: Patent infringement complaint filed following a Paragraph IV certification: Abbott Laboratories et al. v. [read post]
24 May 2012, 1:02 pm
Abbott Laboratories Inc. [read post]
15 Mar 2007, 6:33 am
Abbott Laboratories, Inc., 2006 WL 3457617, *12 (D. [read post]
15 Jul 2010, 2:39 pm
Abbott Laboratories, 607 P.2d 924 (Cal. 1980), a DES case. [read post]
